144 related articles for article (PubMed ID: 26676816)
1. Genome-Wide Association Studies in Drug-Induced Liver Injury: Step Change in Understanding the Pathogenesis.
Aithal GP; Grove JI
Semin Liver Dis; 2015 Nov; 35(4):421-31. PubMed ID: 26676816
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
Grove JI; Aithal GP
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
Aithal GP
Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis of drug-induced liver injury: present and future.
Urban TJ; Daly AK; Aithal GP
Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
[TBL] [Abstract][Full Text] [Related]
5. Genetic risk factors in the development of idiosyncratic drug-induced liver injury.
Stephens C; Lucena MI; Andrade RJ
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):153-169. PubMed ID: 33222552
[No Abstract] [Full Text] [Related]
6. Genetic Predisposition to Drug-Induced Liver Injury.
Stephens C; Andrade RJ
Clin Liver Dis; 2020 Feb; 24(1):11-23. PubMed ID: 31753244
[TBL] [Abstract][Full Text] [Related]
7. Predictive genetic testing for drug-induced liver injury: considerations of clinical utility.
Alfirevic A; Pirmohamed M
Clin Pharmacol Ther; 2012 Sep; 92(3):376-80. PubMed ID: 22850601
[TBL] [Abstract][Full Text] [Related]
8. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
[TBL] [Abstract][Full Text] [Related]
9. Genetic association studies in drug-induced liver injury.
Daly AK; Day CP
Semin Liver Dis; 2009 Nov; 29(4):400-11. PubMed ID: 19826974
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
11. Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
Donaldson PT; Daly AK; Henderson J; Graham J; Pirmohamed M; Bernal W; Day CP; Aithal GP
J Hepatol; 2010 Dec; 53(6):1049-53. PubMed ID: 20800921
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury: insights from genetic studies.
Andrade RJ; Robles M; Ulzurrun E; Lucena MI
Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.
Parham LR; Briley LP; Li L; Shen J; Newcombe PJ; King KS; Slater AJ; Dilthey A; Iqbal Z; McVean G; Cox CJ; Nelson MR; Spraggs CF
Pharmacogenomics J; 2016 Apr; 16(2):180-5. PubMed ID: 25987243
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury: past, present and future.
Daly AK
Pharmacogenomics; 2010 May; 11(5):607-11. PubMed ID: 20415545
[TBL] [Abstract][Full Text] [Related]
15. Genetic association studies in drug-induced liver injury.
Daly AK; Day CP
Drug Metab Rev; 2012 Feb; 44(1):116-26. PubMed ID: 21913872
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.
Dara L; Liu ZX; Kaplowitz N
Liver Int; 2016 Feb; 36(2):158-65. PubMed ID: 26484420
[TBL] [Abstract][Full Text] [Related]
17. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
18. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
19. Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
Nicoletti P; Aithal GP; Chamberlain TC; Coulthard S; Alshabeeb M; Grove JI; Andrade RJ; Bjornsson E; Dillon JF; Hallberg P; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Wadelius M; Shen Y; Nelson MR; Daly AK;
Clin Pharmacol Ther; 2019 Jul; 106(1):245-253. PubMed ID: 30661239
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of drug-induced liver injury.
Russmann S; Jetter A; Kullak-Ublick GA
Hepatology; 2010 Aug; 52(2):748-61. PubMed ID: 20607838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
